Zentalis is a startup based in Unknown, most recent round IPO, 4 tracked investors.
Zentalis is a company founded in 2014 headquartered in Unknown. Its most recent tracked round is IPO. Brouky records 4 investors associated with the company.
Zentalis Pharmaceuticals is a clinical-stage company advancing azenosertib, a first-in-class WEE1 inhibitor, for ovarian cancer and other tumor types.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.